Literature DB >> 10363579

PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors.

N Kawamura1, H Nagai, K Bando, M Koyama, S Matsumoto, T Tajiri, M Onda, J Fujimoto, T Ueki, N Konishi, T Shiba, M Emi.   

Abstract

Allelic loss of loci on chromosome 10q occurs frequently in hepatocellular carcinomas. Somatic mutations of the PTEN/MMAC1 gene on this chromosome at 10q23 were recently identified in sporadic cancers of the uterus, brain, prostate and breast. To investigate the potential role of PTEN/MMAC1 gene in the genesis of hepatocellular carcinomas, we examined 96 tumors for allelic loss on 10q and also for subtle mutations anywhere within the coding region of PTEN/MMAC1 gene. Allelic loss was identified in 25 of the 89 (27%) tumors that were informative for polymorphic markers in the region. Somatic mutations were identified in five of those tumors: three frameshift mutations, a 1-bp insertion at codon 83-84 in exon 4 and two 4-bp deletions, both at codon 318-319 in exon 8; two C-to-G transversion mutation, both at -9 bp from the initiation codon in the 5' non-coding region of exon 1. No missense mutation was observed in this panel of tumors. In most of the informative tumors carrying intragenic mutations of one allele, we were able to detect loss of heterozygosity as well. These findings suggest that two alleles of the PTEN/MMAC1 gene may be inactivated by a combination of intragenic point mutation on one allele and loss of chromosomal material on the other allele in some of these tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10363579      PMCID: PMC5926086          DOI: 10.1111/j.1349-7006.1999.tb00763.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

1.  Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.

Authors:  H P Wang; C E Rogler
Journal:  Cytogenet Cell Genet       Date:  1988

2.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

3.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

5.  PTEN/MMAC1 mutations in endometrial cancers.

Authors:  J I Risinger; A K Hayes; A Berchuck; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

6.  Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.

Authors:  Y Yumoto; T Hanafusa; H Hada; T Morita; S Ooguchi; N Shinji; T Mitani; K Hamaya; N Koide; T Tsuji
Journal:  J Gastroenterol Hepatol       Date:  1995 Mar-Apr       Impact factor: 4.029

7.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Authors:  M Emi; Y Fujiwara; T Nakajima; E Tsuchiya; H Tsuda; S Hirohashi; Y Maeda; K Tsuruta; M Miyaki; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.

Authors:  A T De Souza; G R Hankins; M K Washington; T C Orton; R L Jirtle
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  12 in total

1.  Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma.

Authors:  Zhifang Yang; Jilin Yi; Xingrui Li; Wei Long
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.

Authors:  Vivian A Galicia; Lina He; Hien Dang; Gary Kanel; Christopher Vendryes; Barbara A French; Ni Zeng; Jennifer-Ann Bayan; Wei Ding; Kasper S Wang; Samuel French; Morris J Birnbaum; C Bart Rountree; Bangyan L Stiles
Journal:  Gastroenterology       Date:  2010-09-15       Impact factor: 22.682

3.  MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene.

Authors:  Zengyao Liu; Jiefei Sun; Xiaochun Wang; Zhenyuan Cao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

Review 4.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.

Authors:  Linda S Steelman; William H Chappell; Stephen L Abrams; Ruth C Kempf; Jacquelyn Long; Piotr Laidler; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Franca Stivala; Maria C Mazzarino; Marco Donia; Paolo Fagone; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Michele Milella; Agostino Tafuri; Antonio Bonati; Jörg Bäsecke; Lucio Cocco; Camilla Evangelisti; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

5.  Sequencing the full-length of the phosphatase and tensin homolog (PTEN) gene in hepatocellular carcinoma (HCC) using the 454 GS20 and Illumina GA DNA sequencing platforms.

Authors:  Joel A Rodriguez; Jacfranz J Guiteau; Lynne Nazareth; Jeff G Reid; John A Goss; Richard A Gibbs; Marie-Claude Gingras
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

6.  Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction.

Authors:  Li-Rong Yin; Ze-Xiong Chen; Shi-Jun Zhang; Bao-Guo Sun; Yong-Dong Liu; Hong-Zhong Huang
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 7.  Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

Authors:  Melchiorre Cervello; James A McCubrey; Antonella Cusimano; Nadia Lampiasi; Antonina Azzolina; Giuseppe Montalto
Journal:  Oncotarget       Date:  2012-03

Review 8.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

9.  The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma.

Authors:  Dong-Dong Lu; Yi-Cun Chen; Xi-Ran Zhang; Xiang-Rong Cao; Hua-Yun Jiang; Lin Yao
Journal:  Yale J Biol Med       Date:  2003

Review 10.  The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.

Authors:  Galina Khemlina; Sadakatsu Ikeda; Razelle Kurzrock
Journal:  Mol Cancer       Date:  2017-08-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.